/PRNewswire/ Tesis Biosciences, the leader in targeted genetic sequencing, has developed a new test that identifies the genetic mutations that puts people.
/PRNewswire/ Tesis Biosciences, the leader in targeted genetic sequencing, has announced a new predictive genomic assay that will allow physicians to more.
On the heels of its Genome Explorations acquisition, the company wants to create a biomarker panel to differentiate mild traumatic brain injury from PTSD.